Johnson & Johnson Continues Unbroken Streak of Dividend Increases

Johnson & Johnson is an unlikely candidate for excitement in the market, but it has one impressive claim to fame - 64 consecutive years of annual dividend increases. This streak puts it among the elite group known as Dividend Kings, companies that have raised their dividends for at least 50 consecutive years.

The company's consistent dividend growth is a testament to its stability and reliability, making it an attractive option for income-minded investors. With a forward-looking dividend yield of around 2.1%, a $10,000 position in Johnson & Johnson would generate close to $210 per year.

While this may not be the highest-yielding dividend stock available, it's worth noting that Johnson & Johnson has become more than just an income investment since 2024. The company has made significant acquisitions in the oncology space, including Shockwave Medical and Firefly Bio, which are expected to drive growth.

As a result, investors who buy into Johnson & Johnson can expect a mix of both dividend income and potential for long-term capital appreciation.